MYND Life Sciences (XCNQ:MYND) Current Accrued Expense : C$0.69 Mil (As of Jul. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences Current Accrued Expense?

MYND Life Sciences's Current Accrued Expense for the quarter that ended in Jul. 2024 was C$0.69 Mil.

MYND Life Sciences's quarterly Current Accrued Expense increased from Jan. 2024 (C$0.50 Mil) to Apr. 2024 (C$0.53 Mil) and increased from Apr. 2024 (C$0.53 Mil) to Jul. 2024 (C$0.69 Mil).

MYND Life Sciences's annual Current Accrued Expense increased from Oct. 2021 (C$0.07 Mil) to Oct. 2022 (C$0.22 Mil) and increased from Oct. 2022 (C$0.22 Mil) to Oct. 2023 (C$0.45 Mil).

MYND Life Sciences Current Accrued Expense Historical Data

The historical data trend for MYND Life Sciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences Current Accrued Expense Chart

MYND Life Sciences Annual Data

Trend

Oct21

Oct22

Oct23

Current Accrued Expense

0.07

0.22

0.45

MYND Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Current Accrued Expense	Get a 7-Day Free Trial										0.37	0.45	0.50	0.53	0.69

MYND Life Sciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

MYND Life Sciences Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of MYND Life Sciences's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

MYND Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

MYNDF:USA

Address

105-2248 Elgin Avenue, Port Coquitlam, BC, CAN, V3C 2B2

Website

https://www.myndsciences.com

MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.